Indicators of vegetative homeostasis in children with mitral valve prolapse before and after treatment
For children with mitral valve prolapse (MVP) characterized by disorders of vegetative homeostasis, especially pronounced effect on the body sympathetic link of the autonomic nervous system. In the medical literature, the question of correction of vegetative tone in children with primary MVP is now open. The purpose of the study was to study the parameters of vegetative homeostasis in children with mitral valve prolapse before and after treatment. 66 children with primary and primary MVP stage I and II at the age of 13–17 years were examined. The control group consisted of 23 practically healthy children. The evaluation of vegetative homeostasis was performed using a clinorostatic test and cardiointervalography, followed by an analysis of the parameters and parameters of the heart rate variability spectral analysis. To restore vegetative homeostasis to patients with PMC, an existing treatment regimen with our correction was prescribed. Namely, we added therapies levocarnitine and magnesium. According to the data obtained from the CP, we found that treatment led to the normalization of vegetative maintenance of the organism, mainly in the form of a decrease in the hypersympathicotonic tonic type after treatment, along with the baseline (p<0.05). Consequently, the proposed treatment scheme with the use of levocarnitine and magnesium, positively affects the autonomic system in children with primary MVP, reducing its dysfunction.
2. Soldatova, O. V. (2003). Osoblyvosti vehetatyvnoho homeostazu ta likuvannia ditei z prolapsom mitralnoho klapana [Features of autonomic homeostasis and treatment of children with mitral valve prolapsed]. (Dys. kand. med. nauk). Natsionalnyi medychnyi un-t im. O.O.Bohomoltsia, Kyiv.
3. Tokarchuk, N. I., Vyzhha, Yu. V., & Starynets, L. S. (2016). Zastosuvannia levokarnitynu dlia likuvannia vtorynnoi kardiomiopatii u ditei rannoho viku [The use of levocarnitine for treatment of secondary cardiomyopathy in young children]. Sovremennaya pediatriya – Modern pediatrics, 5 (77), 67–70.
4. Kuleshov, A. V., & Medrazhevskaya, Ya. A. (2019). Klinicheskie osobennosti prolapsa mitralnogo klapana u detej i puti ih korrekcii [Clinical features of mitral valve prolapse in children and methods if it’s correction]. Medicina i farmacevtika: el. nauchnyj zhurnal – Medicine and Pharmaceuticals: e-scientific journal, 1 (2), 8–13.
5. Churilina, A. V. (2004). Prolaps mitralnogo klapana u detej: mehanizmy razvitiya i podhody k reabilitacii [Mitral valve prolapse in children: mechanisms of development and approaches to rehabilitation]. (Dis. d-ra med. nauk). Doneckij gos. medicinskij un-t im. M.Gorkogo, Doneck.
This work is licensed under a Creative Commons Attribution 4.0 International License.